Welcome to TRANSEURO

TRANSEURO is a European research consortium with the principal objective to develop an efficacious and safe treatment methodology for patients suffering from Parkinson’s disease using fetal cell based treatments https://aucasinosonline.com/nz/. The consortium has gathered international experts including leading clinicians, scientists, industrial partners, ethicists and patients’ representatives who have joined forces in a new round of experimental work and cell therapy trials in Parkinson's Disease online casino sites at kiwigambling.co.nz.

TRANSEURO is coordinated by Prof. Roger Barker from Cambridge University and is funded by the 7th Framework Program of the European Commission, Contract number HEALTH-F5-2010-242003.


Latest news
First Transeuro transplant: The first Transeuro procedure took place in Cambridge on the 18th of May 2015.   First Swedish Transeuro transplant: The first Transeuro procedure in Lund took place on the 8th of April 2016.
Consortium Thematic Workshop on " Cells for patients: meeting the GMP challenge"- September 2-3, 2013, Cardiff, UK   Press release, November 7, 2014 - Stem cell transplants for Parkinson’s disease edging closer | article |
Press release, November 27, 2012 (Swedish) Transplantation av hjärnceller i början på 2013 | more |   "Ny metod ska hejda parkinson" - The Transeuro project described in Swedish newspaper SYDSVENSKAN | more... |


Press release, November 30, 2012 Transplant of brain cells for Parkinson's patients In early 2013 | more... |    


    EU flag
    Last update: December 2017

@ Copyright 2017 TRANSEURO


Home disease objectives contact intranet